Literature DB >> 11259147

Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure; the OSCUR study. Oucome dello Scompenso Cardiaco in relazione all'Utilizzo delle Risore.

P Bellotti1, L P Badano, N Acquarone, R Griffo, G Lo Pinto, A P Maggioni, C Mattiauda, G Menardo, P Mombelloni.   

Abstract

AIMS: This study was designed to identify potential specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for congestive heart failure in departments of cardiology or internal medicine. METHODS AND
RESULTS: From 1 July to 31 December 1998, we prospectively recorded epidemiological and clinical data from patients with congestive heart failure consecutively admitted to 11 departments of cardiology and 12 departments of internal medicine in Liguria, a northern area of Italy. The overall study population included 749 patients; 22% were treated by cardiologists and 78% by internists (P<0.0001). Patients managed by cardiologists were more likely to undergo echocardiography (92% vs 37%), Holter monitoring (25% vs 3%) and exercise stress testing (20% vs 0.5%) than those managed by internists (P=0.001). At discharge, patients treated by cardiologists were more likely to be prescribed beta-blockers (41% to 4%) and ACE inhibitors (100% to 74%) than those treated by internists (P<0.0001), and the latter medication at higher dosages by cardiologists than internists. In addition, patients followed by cardiologists were younger (70+/-9 to 79+/-1 years;P<0.0001), more likely to be male (61% to 50%;P=0.011) and to have coronary artery disease (57% to 45%;P<0.006) than those followed by internists. Conversely, patients followed by internists were more likely to have diabetes, chronic obstructive pulmonary disease, atrial fibrillation and renal failure (P<0.03). In the overall study population, 53 patients (7%) died during hospitalization. Patients treated by cardiologists had a mortality not significantly different from that of patients treated by internists (10% and 6%, respectively;P=0.067), although congestive heart failure was more severe on admission in patients treated by cardiologists.
CONCLUSION: Cardiologists follow published guidelines for congestive heart failure more strictly than internists, but treat a smaller number of patients who are younger, have more severe congestive heart failure and fewer co-morbidities than those managed by internists. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259147     DOI: 10.1053/euhj.2000.2362

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

1.  In-hospital management of heart failure: in 10 years we have improved, but not enough.

Authors:  Sonia Ferretto; Chiara Dalla Valle; Sonia Cukon Buttignoni; Luca Brugnaro; Giovanni Maria Boffa
Journal:  Intern Emerg Med       Date:  2010-12-09       Impact factor: 3.397

Review 2.  Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure.

Authors:  Carlo Rostagno; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2008-02-26       Impact factor: 3.397

3.  Clinical trials in heart failure: may we trust?

Authors:  Bruno Trimarco; Alessandro Bellis
Journal:  Intern Emerg Med       Date:  2009-12       Impact factor: 3.397

4.  Stroke prevention in patients with atrial fibrillation: the diagnosis and management of hypertension by specialists.

Authors:  Jeff S Healey; Sean Wharton; Saif Al-Kaabi; Menaka Pai; Amir Ravandi; Girish Nair; Carlos A Morillo; Stuart J Connolly
Journal:  Can J Cardiol       Date:  2006-05-01       Impact factor: 5.223

5.  Impact of specialist follow-up in outpatients with congestive heart failure.

Authors:  Justin A Ezekowitz; Carl van Walraven; Finlay A McAlister; Paul W Armstrong; Padma Kaul
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

6.  Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care.

Authors:  Òscar Miró; V Íctor Gil; Francisco Javier Martín-Sánchez; Javier Jacob; Pablo Herrero; Aitor Alquézar; Lluís Llauger; Sira Aguiló; Gemma Martínez; José Ríos; Alberto Domínguez-Rodríguez; Veli-Pekka Harjola; Christian Müller; John Parissis; W Frank Peacock; Pere Llorens
Journal:  Clin Res Cardiol       Date:  2018-03-28       Impact factor: 5.460

7.  Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.

Authors:  Richard Steinacher; John T Parissis; Bernhard Strohmer; Jörg Eichinger; Dennis Rottlaender; Uta C Hoppe; Johann Altenberger
Journal:  Clin Res Cardiol       Date:  2012-03-07       Impact factor: 5.460

8.  Long-term management of chronic heart failure patients in internal medicine.

Authors:  Anna Belfiore; Vincenzo Ostilio Palmieri; Carla Di Gennaro; Enrica Settimo; Maria Grazia De Sario; Stefania Lattanzio; Margherita Fanelli; Piero Portincasa
Journal:  Intern Emerg Med       Date:  2019-01-18       Impact factor: 3.397

9.  Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: arrhythmia incidence and device performance.

Authors:  Andreas Schuchert; Giuseppe Boriani; Christian Wollmann; Mauro Biffi; Martin Kühl; Johannes Sperzel; Sascha Stiller; Gianni Gasparini; Dirk Böcker
Journal:  J Interv Card Electrophysiol       Date:  2005-03       Impact factor: 1.900

10.  Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice.

Authors:  Giorgio Costantino; Anna Maria Rusconi; Pier Giorgio Duca; Stefano Guzzetti; Ilaria Bossi; Marta Del Medico; Giuseppina Pisano; Mara Bulgheroni; Monica Solbiati; Raffaello Furlan; Nicola Montano
Journal:  Intern Emerg Med       Date:  2008-08-09       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.